CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Preventive informationWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug540 Certified cloth face mask plus preventive information Wiki 1.00
drug1244 Interview by psychologists Wiki 1.00

Correlated MeSH Terms (6)


Name (Synonyms) Correlation
D006948 Hyperkinesis NIH 0.71
D002659 Child Development Disorders, Pervasive NIH 0.58
D001289 Attention Deficit Disorder with Hyperactivity NIH 0.50
D001321 Autistic Disorder NIH 0.50
D000067877 Autism Spectrum Disorder NIH 0.41
D004194 Disease NIH 0.18

Correlated HPO Terms (4)


Name (Synonyms) Correlation
HP:0002487 Hyperkinetic movements HPO 0.71
HP:0000717 Autism HPO 0.50
HP:0007018 Attention deficit hyperactivity disorder HPO 0.50
HP:0000729 Autistic behavior HPO 0.41

There is one clinical trial.

Clinical Trials


1 Evaluation of Locally Produced Cloth Face Mask on COVID-19 and Respiratory Illnesses Prevention at the Community Level - a Cluster-randomized Trial

The number of cases of COVID-19 is still increasing and transmission of SARS-CoV-2 seems to occur mainly through person-to-person transmission through respiratory droplets, indirect contact with infected people and surfaces. The use of face masks is recommended as a public health measure, but in many settings only domestic cloth made masks are available to the majority of the people. However, masks can be of different quality and very little is known about the utility of cloth face masks at the community level. In Bandim Health Project's Health and Demographic Surveillance System we will evaluate the effect of providing locally produced cloth face masks on severity of COVID-19 like illness and mortality in an urban population. The locally produced cloth mask is made according to a laboratory certified model and will be provided to the intervention group alongside information of how the risk of transmission can be reduced. The control group will receive information alone. Follow-up will be implemented through telephone calls and post-epidemic home visits.

NCT04471766 COVID-19 Respiratory Illness Other: Certified cloth face mask plus preventive information Behavioral: Preventive information

Primary Outcomes

Description: Self-reported main symptoms of COVID-19 (three or more - fever, cough, fatigue, shortness of breath, loss of smell / taste)

Measure: Reported COVID-like illness

Time: Four months follow-up

Description: Consultation for COVID-19 like illness or/and reported positive test

Measure: Consultation

Time: Four months follow-up

Description: Self reported COVID-19 like illness plus hospitalization or death

Measure: Severe illness

Time: Four months follow-up

Description: Any death during the follow-up period

Measure: Mortality

Time: Four months follow-up


No related HPO nodes (Using clinical trials)